AutoBio maintains a living, evidence-grounded system of record that tracks competitor studies from early development through approval. Trial designs, endpoints (PFS, OS, ORR, DOR), efficacy readouts, and safety signals are normalized across heterogeneous studies—so teams can see what’s comparable, what’s not, and why.

Updates propagate automatically as trials initiate, read out, publish, or change status. Experts oversee comparability and guardrails, preserving scientific discipline and preventing cross-trial overreach. Competitive awareness stays current, factual, and defensible—without drifting into interpretation.

Typical Outputs

• Cross-phase competitive study comparison tables

• Normalized endpoint and outcome crosswalks

• Safety and AE-of-interest tracking by therapeutic area

• Study design and comparability annotations

• Living update logs with source traceability

Primary Users

• Medical Affairs teams monitoring evolving competitor data

• Clinical and development leaders assessing trial design and endpoint alignment

• MSLs and scientific teams preparing evidence-grounded discussions

• Competitive intelligence and knowledge owners maintaining up-to-date benchmarks